News
- 2025.02.27
- Notice of Convocation of the 20th Ordinary General Meeting of Shareholders
- 2025.02.20
- Notice Regarding the Cancellation of the Issuance of the 6th Unsecured Convertible Bonds with Stock Acquisition Rights and Change in the Use of Net Proceeds
- 2025.02.06
- Notice Regarding Change in Allotment Resolution Dates for the 6th and 7th Unsecured Convertible Bonds with Stock Acquisition Rights
- 2025.02.06
- Summary of Financial Statements for the Fiscal Year Ended December 31, 2024 [Japanese GAAP]（Consolidated）
- 2025.02.06
- SymBio Initiates Phase 1b/2 Clinical Trial of IV Brincidofovir in Patients with Lymphoma in Singapore
Selection News
- 2025.02.26
- 2024年12月期決算説明会の動画を掲載しました。(Japanese only)
- 2025.02.13
- 決算説明会資料（2024年12月期）(Japanese only)
- 2024.12.26
- 株主通信「SymBio VISION vol.26」(Japanese only)
- 2024.08.13
- Article on 2024 1H Earnings Call Featured in Nikkei Biotech Online (Japanese only)
Source: Nikkei Biotech ONLINE, 2024.08.07
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or product/service.
Unauthorized reproduction, duplication, or electronic storage of the articles/photos/charts, etc. is prohibited.
- 2023.11.17
- Notice of Relocation of Head Office